BFNH Bioforce Nanosciences Holdings, Inc.

Fundamentals / CIK 0001310488 / USD

Bioforce Nanosciences Holdings, Inc. reported $786 in total assets and a net loss of $323K through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BFNH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$16.75M$8.37M$0-$148.1MFY 2017 Revenue: $4.5KFY 2017 Net Income: -$31K2017FY 2018 Revenue: $16KFY 2018 Net Income: -$68K2018FY 2019 Revenue: $18KFY 2019 Net Income: -$47K2019FY 2020 Net Income: -$158.4M2020FY 2021 Net Income: -$502K2021FY 2022 Net Income: -$486K2022FY 2023 Net Income: -$472K2023FY 2024 Net Income: -$490K2024FY 2025 Net Income: -$1.29M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- -- $18K $16K $4.5K
Cost of Revenue -- -- -- -- -- -- $13K $12K $3.2K
Gross Profit -- -- -- -- -- -- $4.4K $4.7K $1.3K
Total Operating Expenses $490K $490K $472K $486K $502K $158.4M $51K -- --
Operating Income -- -- -- -- -- -- -$47K -$67K -$31K
Income Before Tax -$490K -$490K -- -- -- -- -$47K -$68K -$31K
Income Tax Expense -- -- -- -- -- -- $0 $0 --
Net Income -$1.29M -$490K -$472K -$486K -$502K -$158.4M -$47K -$68K -$31K
Basic EPS -$0.04 -$0.02 -$0.02 -$0.02 -$0.02 -$9.72 $0.00 $0.00 $0.00
Diluted EPS -$0.04 -$0.02 -$0.02 -$0.02 -$0.02 -$9.72 $0.00 $0.00 $0.00
Basic Shares Outstanding 33.2M 29.3M 29.3M 29.3M 29.3M 16.3M 15.3M 15.3M 76.2M
Diluted Shares Outstanding 33.2M 29.3M 29.3M 29.3M 29.3M 16.3M 15.3M 15.3M 76.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Total Operating Expenses $342K $262K $118K $118K $116K $123K $133K $123K
Operating Income -$342K -$763K -$133K -- -$116K -$123K -$133K --
Income Before Tax -$342K -$262K -$118K -$118K -$116K -$123K -$133K --
Net Income -$342K $239K -$102K -$118K -$116K -$123K -$935K -$123K
Basic EPS -$0.01 $0.01 $0.00 -- $0.00 $0.00 -$0.03 --
Diluted EPS -$0.01 $0.01 $0.00 -- $0.00 $0.00 -$0.03 --
Basic Shares Outstanding 35.0M 33.5M 33.5M -- 33.5M 33.5M 32.2M --
Diluted Shares Outstanding 35.0M 33.5M 33.5M -- 33.5M 33.5M 32.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $786 $862 $638 $734 $11K $40K $53K $29K $14K
Cash & Short-Term Investments $786 $862 $638 $734 $11K $40K $53K $29K $14K
Accounts Receivable, Net -- -- -- -- -- -- -- $5.7K $4.5K
Total Current Assets $786 $862 $638 $734 $11K $40K $59K $35K $21K
Total Non-Current Assets $0 $0 $0 $0 $0 $0 $0 $0 $0
Total Assets $786 $862 $638 $734 $11K $40K $59K $35K $21K
Total Current Liabilities $619K $2.30M $1.82M $1.35M $873K $400K $12K $5.3K $13K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $619K $2.30M $1.82M $1.35M $873K $400K $12K $5.3K $13K
Common Stock $34K $29K $29K $29K $29K $29K $15K $15K $76K
Retained Earnings -$162.4M -$161.1M -$160.6M -$160.2M -$159.7M -$159.2M -$762K -$715K -$647K
Total Stockholders' Equity -$619K -$2.30M -$1.82M -$1.35M -$862K -$360K $47K $30K $8.2K
Total Equity -$619K -$2.30M -$1.82M -$1.35M -$862K -$360K $47K $30K $8.2K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-12-31 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Cash & Cash Equivalents $786 $32K $307 $6.3K $786 $784 $905 $14K
Cash & Short-Term Investments $786 $32K $307 $6.3K $786 $784 $905 $14K
Total Current Assets $786 $2.00M $2.15M $6.3K $786 $784 $905 $14K
Total Non-Current Assets $0 $235K $235K $0 $0 $0 $0 $0
Total Assets $786 $2.24M $2.39M $6.3K $786 $784 $905 $14K
Total Current Liabilities $619K $277K $85K $727K $619K $501K $385K $275K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $619K $277K $85K $727K $619K $501K $385K $275K
Common Stock $34K $38K $34K $34K $34K $34K $34K $34K
Retained Earnings -$162.4M -$162.6M -$162.3M -$162.5M -$162.4M -$162.3M -$162.2M -$162.1M
Total Stockholders' Equity -$619K $1.96M $2.30M -$721K -$619K -$500K -$384K -$261K
Total Equity -$619K $1.96M $2.30M -$721K -$619K -$500K -$384K -$261K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$1.29M -$490K -$472K -$486K -$502K -$158.4M -$47K -$68K -$31K
Change in Receivables -- -- -- -- -- -- $5.7K -$1.2K -$4.5K
Operating Cash Flow -$65K -$61K -$47K -$68K -$78K -$80K -$24K -$62K -$26K
Financing Cash Flow $65K $61K $47K $58K $49K $67K $48K -- --
Net Change in Cash -$76 $224 -$96 -$10K -$29K -$13K -- -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$342K $239K -$102K -$118K -$116K -$123K -$935K -$123K
Operating Cash Flow -$95K -$27K $7.1K -$11K -$11K -$28K -$15K -$15K
Financing Cash Flow $126K $21K -$1.5K $11K $11K $15K $28K $14K
Net Change in Cash $31K -$6.0K $5.6K $2 -$121 -$13K $13K -$773

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- 24.5% 28.6% 27.9%
Operating Margin -- -- -- -- -- -- -261.8% -409.2% -694.7%
Net Profit Margin -- -- -- -- -- -- -261.8% -415.3% -694.7%
Return on Equity (ROE) -- -- -- -- -- -- -98.4% -227.3% -381.1%
Return on Assets (ROA) -164370.4% -56895.2% -73973.8% -66146.3% -4503.9% -397362.5% -79.0% -192.8% -149.5%
Current Ratio 0.00x 0.00x 0.00x 0.00x 0.01x 0.10x 5.08x 6.60x 1.65x
Quick Ratio 0.00x 0.00x 0.00x 0.00x 0.01x 0.10x 4.57x 6.60x 1.48x
Revenue Growth (YoY) -- -- -- -- -- -- +9.0% +262.4% --
Gross Profit Growth (YoY) -- -- -- -- -- -- -6.5% +271.7% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -16.5% -4.2% -- -- -- -- -- --
Return on Assets (ROA) -14.4% -4.1% -7230.3% -164370.4% -165473.6% -144024.5% -9385.3% -56895.2%
Current Ratio 7.23x 25.41x 0.01x 0.00x 0.00x 0.00x 0.05x 0.00x
Quick Ratio 0.11x 0.00x 0.01x 0.00x 0.00x 0.00x 0.05x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001310488) · from September 30, 2017 Data through December 31, 2026 · synced Nov 20, 2026, 05:43 UTC · Open in terminal